ClearTrial

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ClearTrial
Type Private
Industry Clinical trial software
Founded Chicago, Illinois, USA (2004)
Founders Mike Soenen
Richard Musselman
Headquarters 328 South Jefferson Street, Chicago, Illinois 60661 USA
Area served Global
Key people Mike Soenen, CEO
Michael Bruns, COO
Andrew Grygiel, CMO
Richard Zecca, VP of Worldwide Sales
Products ClearTrial PLAN
ClearTrial SOURCE
ClearTrial TRACK
Employees 50+ (August 1, 2011)
Website cleartrial.com

ClearTrial is a multinational software developer headquartered in Chicago, Illinois, USA. The company develops and markets a software as a service (SaaS) system designed for biopharmaceutical and medical device manufacturers for the planning, outsourcing, and tracking of clinical trials.

The ClearTrial software architecture follows a project management methodology that includes activity-based costing, which predicts the level of effort for a specific resource (person) to perform a given task (activity). The level of effort is calculated based on an algorithm that has been derived from analysis of the cost and time drivers that affect each task. The ClearTrial Work Breakdown Structure defines and groups the tasks and subtasks that comprise a clinical trial in a way that organizes and defines the total work scope of the clinical project.

ClearTrial’s clinical trial subject matter experts (SMEs) have published peer-reviewed articles on functional service provider outsourcing in clinical trials,[1] adaptive clinical trials,[2] and clinical trials for medical devices,[3] as well as articles on clinical trial trends.[4] In April 2011, ClearTrial was named one of five “Cool Vendors in Life Sciences”[5] by the research firm Gartner.

On March 29, 2012, Oracle Corporation announced that it had agreed to acquire ClearTrial. The transaction has closed.

References[edit]

  1. ^ Lucas, K., “Steps to Functional Service Provider Success”, Applied Clinical Trials, August 2008
  2. ^ Blake-Michaels, M., “Operation Adaptive”, Applied Clinical Trials, October 2009
  3. ^ Blake-Michaels, M., “Considerations for Medical Device Trials", Applied Clinical Trials, August 2010
  4. ^ Stergiopoulos, S., Getz, K., Soenen, M., “Honing Reforms from Clinical Development”, Pharmaceutical Executive, February 2011
  5. ^ Lefebure, S., Hagemeyer, D., “Cool Vendors in Life Sciences, 2011”, Gartner, April 2011

External links[edit]